BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3303001)

  • 41. [Randomized control study of high-dose metoclopramide in the prevention of CDDP-induced emesis].
    Sawamura N; Funaki Y; Takahashi S; Yokoyama S; Fujita J; Futami H; Sasaki Y; Yoshioka S; Sakurai M; Eguchi K
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):943-6. PubMed ID: 3885865
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized trial of high dose bolus metoclopramide versus low-dose continuous infusion metoclopramide in the prevention of cisplatin-induced emesis.
    Dana BW; McDermott M; Everts E; Abdulhay G
    Am J Clin Oncol; 1987 Jun; 10(3):253-6. PubMed ID: 3296733
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of continuous and intermittent bolus infusions of metoclopramide during 5-day continuous intravenous infusion with cisplatin.
    Mori K; Saitou Y; Tominaga K; Yokoi ; Miyazawa N
    Eur J Cancer; 1991; 27(6):729-32. PubMed ID: 1648944
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone.
    Kris MG; Gralla RJ; Clark RA; Tyson LB; Fiore JJ; Kelsen DP; Groshen S
    Cancer Treat Rep; 1985 Nov; 69(11):1257-62. PubMed ID: 3912039
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients.
    Kris MG; Gralla RJ; Tyson LB; Clark RA; Kelsen DP; Reilly LK; Groshen S; Bosl GJ; Kalman LA
    Cancer; 1985 Feb; 55(3):527-34. PubMed ID: 3880660
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Betamethasone-dixyrazine combination versus high-dose metoclopramide as antiemetic treatment in doxorubicin and cisplatin chemotherapy.
    Sorbe B; Hallén C; Skåre NG; Underskog I
    Radiother Oncol; 1989 Jun; 15(2):161-7. PubMed ID: 2762589
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prochlorperazine and transdermal scopolamine added to a metoclopramide antiemetic regimen. A controlled comparison.
    Malone JM; Christensen CW; Yashinsky D; Malviya VK; Deppe G
    J Reprod Med; 1990 Oct; 35(10):932-4. PubMed ID: 2246759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study.
    Kenward H; Elliott J; Lee T; Pelligand L
    BMC Vet Res; 2017 Aug; 13(1):244. PubMed ID: 28814338
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Continuous infusion of high-dose metoclopramide: comparison of pharmacokinetically adjusted and standard doses for the control of cisplatin-induced acute emesis.
    Brechot JM; Dupeyron JP; Delattre C; Chastang C; Laaban JP; Rochemaure J
    Eur J Clin Pharmacol; 1991; 40(3):283-6. PubMed ID: 1647955
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.
    Gralla RJ; Itri LM; Pisko SE; Squillante AE; Kelsen DP; Braun DW; Bordin LA; Braun TJ; Young CW
    N Engl J Med; 1981 Oct; 305(16):905-9. PubMed ID: 7024807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metoclopramide kinetics at high-dose infusion rates for prevention of cisplatin-induced emesis.
    Saller R; Hellenbrecht D; Briemann L; Hellstern A; Hess H; Mitrou P; Hodgson M; Achtert G; Brockmann P; Hausleiter HJ
    Clin Pharmacol Ther; 1985 Jan; 37(1):43-7. PubMed ID: 4038385
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The antiemetic activity of high-dose alizapride and high-dose metoclopramide in patients receiving cancer chemotherapy: a prospective, randomized, double-blind trial.
    Joss RA; Galeazzi RL; Bischoff AK; Pirovino M; Ryssel HJ; Brunner KW
    Clin Pharmacol Ther; 1986 Jun; 39(6):619-24. PubMed ID: 3519041
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of antiemetic activity of chloropromazine and high doses of metoclopramide in cisplatin-based chemotherapy.
    Tsavaris NB; Papaioannou D; Beldecos D; Kakoliris S; Mylonakis N; Karvounis N; Komitsopoulou P; Karagiaouris P; Sarmas J; Tzannou I
    Acta Oncol; 1990; 29(8):1005-9. PubMed ID: 2278720
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment of nausea and vomiting induced by a 24-hour i.v. infusion of cisplatin].
    Nagai H; Suga S; Horiuchi Y; Kyokane K; Miwa Y; Aoki Y; Yasue K; Noro T; Kamikawa R; Ninomiya E
    Gan No Rinsho; 1990 Jun; 36(7):791-6. PubMed ID: 2113110
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A phase III trial comparing the antiemetic activity of tetracosactide with dexamethasone in combination with metoclopramide, diphenhydramine and clorazepate during chemotherapy including cisplatin].
    Culine S; Azab M; Pietri F; Ghosn M; Ben Amor B; Lupera H; Theodore C; Renaux J; Droz JP
    Bull Cancer; 1989; 76(6):583-9. PubMed ID: 2673437
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the efficacy of tropisetron versus a metoclopramide cocktail based on the intensity of cisplatin-induced emesis.
    Chang TC; Hsieh F; Lai CH; Tseng CJ; Cheng HH; Li CL; Michael BJ; Soong YK
    Cancer Chemother Pharmacol; 1996; 37(3):279-85. PubMed ID: 8529290
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Randomized controlled study of high-dose metoclopramide and dexamethasone in the prevention of CDDP-induced emesis].
    Umehara H; Sawamura N; Takahashi S; Kusano H; Yokoyama S; Suemasu K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1996-8. PubMed ID: 3010886
    [No Abstract]   [Full Text] [Related]  

  • 58. [Prevention of nausea and emesis during cytostatic therapy. Antiemetic efficacy of high-dosage oral metoclopramide without and with prednisone].
    Senn HJ; Köhler M; Glaus A; Bachmann-Mettler I; Weigand W
    Dtsch Med Wochenschr; 1986 Jan; 111(4):129-35. PubMed ID: 3510848
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Randomized crossover trial of the antiemetic effects obtained with metoclopramide and droperidol versus those obtained with metoclopramide, droperidol and methylprednisolone in patients receiving cis-platinum chemotherapy].
    Fujii M; Kiura K; Tamai M; Okabe K; Toki H
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2562-7. PubMed ID: 3527070
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiemetic efficacy of high-dose corticosteroids and droperidol in cisplatin-induced emesis: a controlled trial with droperidol and metoclopramide.
    Donovitz GS; O'Quinn AG; Smith ML
    Gynecol Oncol; 1984 Jul; 18(3):320-5. PubMed ID: 6540222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.